bioAffinity Technologies Reports 72% Monthly Jump in CyPath Lung Test Sales
Company sees back-to-back record months in June and July, reaffirms forecast of 3X year-over-year revenue growth for noninvasive lung cancer diagnostic.
Read More
Search Results for: lung cancer
Cizzle Biotechnology Expands US Lab Partnership for CIZ1B Lung Cancer Test
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
Read More
FDA Approves Companion Test to Identify Patients Eligible for New NSCLC Treatment
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
Read More
CyPath Lung Flags Early-Stage Cancer Overlooked by Previous Tests
A case study shows how the noninvasive test detected Stage 1A mucinous adenocarcinoma in a high-risk patient whose previous tests and follow-up scans had suggested a low probability of cancer.
Read More
Breath Tests in Clinical Diagnosis Non-invasive Disease Detection
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Read More